SCHEMBL1347716

SCHEMBL1347716

NC(=O)c1cccc(-c2ccc(CNCCCC3CCCCC3)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.50
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CXCR4 P61073 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
FAAH O00519 2/20 0.45
TRPA1 O75762 1/20 0.45
EPHX2 P34913 1/20 0.45
FAAH2 Q6GMR7 1/20 0.45
MGLL Q99685 1/20 0.45
CNR1 P21554 1/20 0.45
NR3C2 P08235 1/20 0.44
ACP1 P24666 1/20 0.44
OPRM1 P35372 3/20 0.43
OPRD1 P41143 3/20 0.43
OPRK1 P41145 2/20 0.43
ADAMTS4 O75173 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.43
SLC6A4 P31645 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1348267 0.93 MEN1 (0.48) SIGMAR1MEN1KMT2ACXCR4HDAC6
SCHEMBL1347674 0.92 OPRM1 (0.48) SIGMAR1MEN1KMT2AHDAC6FAAH
Trifluoroacetic Acid SCHEMBL3343134 0.88 HTR5A (0.47) SIGMAR1MEN1KMT2AHDAC6FAAH
SCHEMBL1345988 0.88 MEN1 (0.57) MEN1KMT2AHDAC6FAAHTRPA1
SCHEMBL1787140 0.88 MEN1 (0.57) MEN1KMT2AHDAC6FAAHTRPA1
Trifluoroacetic Acid SCHEMBL3339696 0.83 MEN1 (0.50) MEN1KMT2AHDAC6FAAHTRPA1
Trifluoroacetic Acid SCHEMBL3345279 0.83 MEN1 (0.50) MEN1KMT2AHDAC6FAAHTRPA1
SCHEMBL1345684 0.83 OPRM1 (0.46) MEN1KMT2AHDAC6FAAHTRPA1
SCHEMBL1347790 0.81 CNR1 (0.43) MGLLCNR1NR3C2OPRM1OPRD1
SCHEMBL1347678 0.80 KDM1A (0.47) HDAC6FAAHTRPA1EPHX2FAAH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US claimed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-8063247-B2 Bicyclic aryl and heteroaryl receptor modulators PROSIDION LIMITED (GB) 2011-11-22 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2010-10-21 US disclosed
WO-2009030962-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS PROSIDION LIMITED (GB) 2009-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267780-A1 BICYCLIC ARYL AND HETEROARYL RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 SIGMAR1 8/4885MEN1 4874/4885KMT2A 1728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.